
Q’Apel Medical Announces U.S. FDA Clearance for the Zebra Neurovascular Access System and Prepares for Full U.S. Launch
FREMONT, Calif., July 8, 2025 /PRNewswire/ — Q’Apel Medical (Q’Apel), a private medical device company focused on revolutionizing neurovascular interventions, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its Zebra Neurovascular Access System. Available in 6F and 7F sizes, Zebra is indicated for the introduction of interventional devices into the peripheral and neurovasculature.